Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes EVP & General Manager US gave up 3,675 shares (to pay taxes)
  6. 4 Shares withheld for taxes Principal Accounting Officer gave up 1,021 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, General Manager, Europe gave up 202 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 202 shares (to pay taxes)
  9. 4 Planned sale EVP & Chief Medical Officer sold 7,365 shares at $65.51 ($482,481)
  10. 4 Planned sale EVP, GMAPPS sold 657 shares at $65.00 ($42,705)
  11. 4 Grant or award Director acquired 1,112 shares (grant or award)
  12. 4 Grant or award Director acquired 412 shares (grant or award)
  13. 4 Grant or award Director acquired 423 shares (grant or award)
  14. 4 Planned sale Principal Accounting Officer sold 1,277 shares at an average $61.55 ($78,594)
  15. 4 Grant or award EVP & General Counsel acquired 26,524 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 1,020 shares (grant or award)
  18. 4 Grant or award Director acquired 389 shares (grant or award)
  19. 4 Grant or award Director acquired 379 shares (grant or award)
  20. 4 Open-market sale EVP, Human Resources sold 8,449 shares at $65.13 ($550,283)

Page 14 of 82 · 1,628 filings